Lilly to participate in Wells Fargo 20th Annual Healthcare Conference
Eli Lilly (NYSE:LLY) announced its participation in the upcoming Wells Fargo 20th Annual Healthcare Conference on September 5, 2025. Patrik Jonsson, executive vice president and president of Lilly International, will participate in a fireside chat at 9:30 a.m. ET.
Investors can access a live audio webcast through Lilly's investor website, with a replay available for approximately 90 days following the presentation.
Eli Lilly (NYSE:LLY) ha comunicato la sua partecipazione al Wells Fargo 20th Annual Healthcare Conference che si terrà il 5 settembre 2025. Patrik Jonsson, vicepresidente esecutivo e presidente di Lilly International, parteciperà a un incontro informale alle 9:30 ET.
Gli investitori potranno seguire una webcast audio in diretta sul sito per gli investitori di Lilly; la registrazione sarà disponibile in replica per circa 90 giorni dopo la presentazione.
Eli Lilly (NYSE:LLY) anunció su participación en el Wells Fargo 20th Annual Healthcare Conference el 5 de septiembre de 2025. Patrik Jonsson, vicepresidente ejecutivo y presidente de Lilly International, participará en una charla informal a las 9:30 a.m. ET.
Los inversores podrán acceder a una retransmisión de audio en vivo a través del sitio web de inversores de Lilly; la grabación estará disponible en reproducción durante aproximadamente 90 días tras la presentación.
Eli Lilly (NYSE:LLY)� 2025� 9� 5일에 개최되는 Wells Fargo 20th Annual Healthcare Conference� 참가한다� 발표했습니다. 국제담당 사장 � 수석부사장� Patrik Jonsson� 오전 9� 30�(동부시간)� 파이어사이드 채팅� 참석합니�.
투자자들은 릴리� 투자� 웹사이트� 통해 라이� 오디� 웹캐스트� 접속� � 있으�, 발표 � � 90일간 재생(리플레이)� 이용� � 있습니다.
Eli Lilly (NYSE:LLY) a annoncé sa participation au Wells Fargo 20th Annual Healthcare Conference le 5 septembre 2025. Patrik Jonsson, vice-président exécutif et président de Lilly International, prendra part à une discussion informelle à 9h30 ET.
Les investisseurs pourront suivre un webcast audio en direct sur le site investisseurs de Lilly ; la rediffusion sera disponible pendant environ 90 jours après la présentation.
Eli Lilly (NYSE:LLY) gab bekannt, dass das Unternehmen am Wells Fargo 20th Annual Healthcare Conference am 5. September 2025 teilnimmt. Patrik Jonsson, Executive Vice President und President von Lilly International, wird um 9:30 Uhr ET an einem Fireside-Chat teilnehmen.
Anleger können den Live-Audio-Webcast über Lilys Investorenseite verfolgen; eine Aufzeichnung steht etwa 90 Tage nach der Präsentation zum Abruf zur Verfügung.
- None.
- None.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healingto make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Ի, or follow us on , , and . F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and � symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; [email protected]; 317-416-4363 (Media) |
Michael Czapar;[email protected]; 317-617-0983 (Investors) |
View original content to download multimedia:
SOURCE Eli Lilly and Company